The outcome of COVID‐19 in patients with hematological malignancy

In this study, we aim to report the outcomes for COVID‐19 in patients with hematological malignancy in Turkey. Data from laboratory‐confirmed 188 897 COVID‐19 patients diagnosed between 11 March 2020 and 22 June 2020 included in the Republic of Turkey, Ministry of Health database were analyzed retro...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Med Virol
Κύριοι συγγραφείς: Yigenoglu, Tugce N., Ata, Naim, Altuntas, Fevzi, Bascı, Semih, Dal, Mehmet Sinan, Korkmaz, Serdal, Namdaroglu, Sinem, Basturk, Abdulkadir, Hacıbekiroglu, Tuba, Dogu, Mehmet H., Berber, İlhami, Dal, Kursat, Erkurt, Mehmet A., Turgut, Burhan, Ulgu, Mustafa Mahir, Celik, Osman, Imrat, Ersan, Birinci, Suayip
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2020
Θέματα:
Research Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436524/
https://ncbi.nlm.nih.gov/pubmed/32776581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26404
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια